We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$48.3B
AUM Growth
+$4.2B
Cap. Flow
-$749M
Cap. Flow %
-1.55%
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 16.39%
3 Financials 11.55%
4 Consumer Discretionary 10.38%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYB icon
376
LyondellBasell Industries
LYB
$19.8B
$23.7M 0.05%
248,900
-5,700
-2% -$533K
AMK
377
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$23.6M 0.05%
789,298
+1,338
+0.2% +$34.3K
TTMI icon
378
TTM Technologies
TTMI
$14.2B
$23.6M 0.05%
1,495,000
+70,000
+5% +$975K
INZY
379
DELISTED
Inozyme Pharma
INZY
$23.6M 0.05%
5,537,500
KEYS icon
380
Keysight
KEYS
$57.6B
$23.6M 0.05%
148,035
-4,800
-3% -$652K
QRVO icon
381
Qorvo
QRVO
$8.41B
$23.5M 0.05%
208,875
+111,575
+115% +$10.8M
DO
382
DELISTED
Diamond Offshore Drilling, Inc.
DO
$23.4M 0.05%
1,797,506
+925,787
+106% +$12M
HR icon
383
Healthcare Realty
HR
$6.92B
$23.3M 0.05%
1,350,000
-1,300,000
-49% -$19.9M
STT icon
384
State Street
STT
$50.8B
$23.2M 0.05%
299,732
-17,100
-5% -$1.19M
CEG icon
385
Constellation Energy
CEG
$93.2B
$23.1M 0.05%
197,777
-122,000
-38% -$14.2M
CNTA
386
DELISTED
Centessa Pharmaceuticals
CNTA
$23.1M 0.05%
2,896,128
+65,628
+2% +$440K
KRC icon
387
Kilroy Realty
KRC
$4.34B
$22.9M 0.05%
575,292
+257,188
+81% +$8.48M
DG icon
388
Dollar General
DG
$28.1B
$22.9M 0.05%
168,200
-49,900
-23% -$6.05M
SLG icon
389
SL Green Realty
SLG
$3.86B
$22.8M 0.05%
505,462
+165,331
+49% +$6.1M
FITB
390
Fifth Third Bancorp
FITB
$51.7B
$22.8M 0.05%
661,597
-15,500
-2% -$430K
ROK icon
391
Rockwell Automation
ROK
$49.2B
$22.8M 0.05%
+73,400
New +$20.6M
NKTX icon
392
Nkarta
NKTX
$164M
$22.8M 0.05%
3,450,000
+3,310,700
+2,377% +$8.58M
TCRX icon
393
TScan Therapeutics
TCRX
$49.9M
$22.7M 0.05%
3,900,000
-100,000
-3% -$458K
GLW icon
394
Corning
GLW
$135B
$22.7M 0.05%
745,821
-17,400
-2% -$498K
ANNX icon
395
Annexon
ANNX
$918M
$22.7M 0.05%
4,999,975
+2,650,000
+113% +$6.56M
SNY icon
396
Sanofi
SNY
$104B
$22.4M 0.05%
+450,000
New +$22M
J icon
397
Jacobs Solutions
J
$16.9B
$22.4M 0.05%
208,338
+56,942
+38% +$6.2M
ROST icon
398
Ross Stores
ROST
$81.6B
$22.3M 0.05%
160,886
+47,200
+42% +$5.88M
MCB icon
399
Metropolitan Bank Holding Corp
MCB
$1.15B
$22.2M 0.05%
400,000
-113,242
-22% -$4.47M
MTB icon
400
M&T Bank
MTB
$36.1B
$22.1M 0.05%
161,307
-3,700
-2% -$465K

Similar funds

Adage Capital Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
  • Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
  • Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
  • Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
  • Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
  • Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
  • Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.